End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.68 CNY | +6.16% | +1.23% | +11.83% |
11-25 | Meihua Holding to Buy Assets of Kirin's Unit; Shares Drop 3% | MT |
11-25 | Kirin to Transfer Kyowa Hakko Bio's Amino Acid, Human Milk Oligosaccharide Businesses to Meihua for 10.5 Billion Yen | MT |
Capitalization | 30.47B 4.21B 3.99B 3.71B 3.31B 5.89B 356B 6.46B 45.93B 17.1B 146B 15.8B 15.45B 633B | P/E ratio 2024 * |
9.98x | P/E ratio 2025 * | 9.13x |
---|---|---|---|---|---|
Enterprise value | 30.47B 4.21B 3.99B 3.71B 3.31B 5.89B 356B 6.46B 45.93B 17.1B 146B 15.8B 15.45B 633B | EV / Sales 2024 * |
1.04x | EV / Sales 2025 * | 0.98x |
Free-Float |
59.46% | Yield 2024 * |
2.81% | Yield 2025 * | 3.04% |
1 day | +6.16% | ||
1 week | +1.23% | ||
1 month | +13.02% | ||
3 months | +11.13% | ||
6 months | -2.73% | ||
Current year | +11.83% |
Director | Title | Age | Since |
---|---|---|---|
Jun He
CEO | Chief Executive Officer | 50 | 15/01/2017 |
Li Hong Wang
DFI | Director of Finance/CFO | 43 | 05/09/2019 |
Li Bin Chang
CTO | Chief Tech/Sci/R&D Officer | 55 | - |
Manager | Title | Age | Since |
---|---|---|---|
Jun He
BRD | Director/Board Member | 50 | 20/01/2011 |
Li Zhi Cui
BRD | Director/Board Member | 54 | 12/02/2014 |
Xue Mei Yang
BRD | Director/Board Member | 49 | 26/01/2016 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.38% | 12 M€ | -16.71% | - |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+6.16% | +1.23% | +11.83% | +40.71% | 4.21B | ||
+2.47% | +3.70% | +18.45% | -46.94% | 34.57B | ||
+0.59% | +0.61% | +21.20% | -35.74% | 23.36B | ||
-3.10% | -2.20% | -9.46% | -5.23% | 10.38B | ||
-0.11% | -0.29% | +12.02% | +27.11% | 5.12B | ||
-0.27% | -0.07% | +19.45% | +0.37% | 4.16B | ||
+0.70% | +0.15% | -5.53% | -38.43% | 4.08B | ||
-0.29% | -4.34% | +33.33% | +48.98% | 3.18B | ||
+7.54% | +9.44% | -28.02% | -28.37% | 2.48B | ||
+1.54% | +3.52% | -7.56% | -21.51% | 1.99B | ||
Average | +1.52% | +1.99% | +6.57% | -5.90% | 9.35B | |
Weighted average by Cap. | +1.23% | +1.80% | +13.10% | -24.75% |
2024 * | 2025 * | |
---|---|---|
Net sales | 29.16B 4.03B 3.82B 3.55B 3.17B 5.64B 341B 6.18B 43.96B 16.37B 140B 15.13B 14.79B 606B | 31.09B 4.29B 4.07B 3.79B 3.38B 6.02B 363B 6.59B 46.87B 17.45B 149B 16.13B 15.77B 646B |
Net income | 3.05B 421M 399M 371M 332M 590M 35.62B 647M 4.6B 1.71B 14.61B 1.58B 1.55B 63.39B | 3.34B 461M 437M 406M 363M 646M 38.97B 708M 5.03B 1.87B 15.99B 1.73B 1.69B 69.35B |
Net Debt | - | - |
Date | Price | Change | Volume |
---|---|---|---|
29/11/24 | 10.68 ¥ | +6.16% | 59,424,310 |
28/11/24 | 10.06 ¥ | -0.49% | 25,589,510 |
27/11/24 | 10.11 ¥ | +0.10% | 31,248,100 |
26/11/24 | 10.10 ¥ | -1.17% | 22,801,700 |
25/11/24 | 10.22 ¥ | -3.13% | 50,615,090 |
End-of-day quote Shanghai S.E., November 28, 2024
More quotesAnnual profits - Rate of surprise
- Stock Market
- Equities
- 600873 Stock
MarketScreener is also available in this country: United States.
Switch edition